ArticleCancers2024

Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial.

Hans Van der Eecken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.